Fortress Biotech News

3: Initial statement of beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

May 24 16:08 ET

4: Statement of changes in beneficial ownership of securities-Officer ROSENWALD LINDSAY A MD

May 20 17:06 ET

4: Statement of changes in beneficial ownership of securities-Director Klein Dov

May 20 17:02 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(11.2%)

May 17 17:18 ET

S-3: Registration statement for specified transactions by certain issuers

May 17 17:04 ET

144: Notice of proposed sale of securities pursuant to Rule 144

May 17 13:18 ET

10-Q: Quarterly report

May 15 22:23 ET

8-K: Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

May 15 16:31 ET

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(8.0%)

Apr 17 16:11 ET

4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Apr 17 16:10 ET

Fortress Biotech | DEFA14A: Others

Apr 5 17:34 ET

Fortress Biotech | DEF 14A: Definitive information statements

Apr 5 17:34 ET

Fortress Biotech | 424B3: Prospectus

Apr 5 17:19 ET

Fortress Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Jin David

Apr 2 16:13 ET

Fortress Biotech | 8-K: Current report

Mar 28 22:40 ET

Fortress Biotech | 10-K: Annual report

Mar 28 22:24 ET

Fortress Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(7.5%)

Mar 22 18:28 ET

Fortress Biotech | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Mar 22 18:28 ET

Fortress Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(4.2%),Wilmot B. Harkey(4.2%), etc.

Feb 14 16:58 ET

Fortress Biotech | 8-K: Current report

Jan 26 16:12 ET